IFNA1 and COVID-19: The recent report that autoantibodies to IFN type I occur in severe cases of COVID-19 and account, in even a larger number of instances than for genetic defects of IFN-α production, for higher mortality especially in younger patients [84,85,86] has revived the interest in this neglected field of study.